The global cell analysis instruments market is anticipated to register significant growth over the forecast period driven by the growing prevalence of chronic conditions such as cancer coupled with the increasing effect of cell-based diseases, especially among the geriatric population. In addition, the growing cell-based research activities coupled with growing partnerships among public and private entities is projected to fuel demand for cell analysis instruments market growth over the forecast period.
In addition, it is expected that automation of cancer research and the implementation of cell analysis for cell detection would present new prospects for the demand for global cell analysis methods. The gradual replacement of obsolete technology with modern technologies and the lack of trained specialists, however are some of the factors challenging cell analysis instruments market growth.
Adroit Market Research report on global cell analysis instruments market gives a holistic view of the market from 2018 to 2028, which includes factors such as market drivers, restraints, opportunities, and challenges. The market has been studied for the period 2018 to 2028, with the base year of estimation as 2019 and forecast from 2020 to 2028. The report covers the current status and future traits of the market at global as well as country level. In addition, the study also assesses the market competition with Porter's five forces analysis and company positioning based on their product portfolio, geographic footprint, strategic initiatives and overall revenue. Prominent players operating in the global cell analysis instruments market have been studied in detail.
North America currently holds the largest share in cell analysis instruments market owing to the presence of significant number of major players across the region along with growing investments by the established firms. However, Asia Pacific is going to record growth at a faster pace on account of growing geriatric population especially across emerging economies such as India, China, and Japan in particular. Furthermore, the market growth across the Asia Pacific region is attributed to rising government focus on development of advanced healthcare facilities for the growing population.
The prominent players operating in global cell analysis instruments market includes BD, Sartorius AG, Danaher, Merck KGaA, Thermo Fisher Scientific Inc., Miltenyi Biotec, Terumo BCT, Promega Corporation, GE Healthcare among other prominent players.
Key segments of the global cell analysis instruments market
Product Overview, 2018-2028 (USD Million)
- Instruments
- Consumables
Application Overview, 2018-2028 (USD Million)
- Cell Counting
- Cell Viability
- Cell Identification
- Target Identification
- Others
End-User Overview, 2018-2028 (USD Million)
- Academic and Research Institutes
- Pharmaceutical & Biotechnology Companies
- Others
Regional Overview, 2018-2028 (USD Million)
- North America
- U.S.
- Canada
- Europe
- Germany
- United Kingdom
- France
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
- South America
- Brazil
- Mexico
- Rest of South America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East and Africa